On Demand Webinars
Microbial Impact Assessment of In-Process Bioburden Limit Excursions
Presented by Friedrich von Wintzingerode, PhD. Director, Microbiology and QC individualized and cell therapy at Genentech, Cheryl Essex, MS. Head of Contamination Control, R&D Global Quality at Sanofi and Jon Kallay, Senior Scientific Portfolio Specialist, Charles River Microbial Solutions
20th March 2025
Navigating the Complexities of mRNA Therapies Analysis: Challenges, Techniques, and Quality Assessment Strategies
Presented by Sarita Kattel, M.S, Principal Scientist, Global Biologics at USP, Khaled Yamout, CEO at Yamout Chem Consulting, LLC, Martin Gilar, Ph.D., Scientific Fellow, Seperations R&D group at Water Corporation, Roxanna Eggleston-Rangel, Applications Scientist at Phenomenex
27th February 2025
Case Study: A Risk-Based Approach to Material Transfer Validation
Presented by Presented by Liz Brockson, Aseptic Processing and Sterility Assurance Lead in Global Sterility Assurance and Microbiology at Takeda
19th February 2025
The Critical Role of Conversion Factor in Quantitative Determination of Host Cell DNA with dPCR
Presented by Haiqing Yu, Senior Scientist, Analytical Development Department at Sanofi.
04th February 2025
Deciphering Empty-Full Characterization: A Comparative Analysis of Available Analytical Methods
Presented by Binod Pandey, Senior Scientist at Novartis
03rd February 2025
Leveraging Instrumentation to Accelerate Release Testing & Minimize Human Input
Presented by Therese Choquette, Head of Analytical and Translational Sciences at Tigen Pharma and Zhong Yu, Snr. Business Development Manager at Axion BioSystems, Allen L. Burgenson, Global Subject Matter Expert, Testing Solutions at Lonza, Félix Montero-Julian, Scientific Director of Pharma Quality Control at bioMérieux
16th January 2025
Current Status and Overview of the Rapid Microbiological Methods and Endotoxin Microbiology USP Chapters under Development
Presented by Jay Bolden, Senior Director, Eli Lilly and Company Global Quality Laboratories, Dr David Roesti, PhD. Microbiologist/Facilitator QA/QC at Novartis Pharma AG, Veronika Wills, Manager, Technical Services at Associates of Cape Cod, Inc, Nicola Reid, Associate Director of Endotoxin Products at Charles River, Lamin Jallow, Microbiology Technology Specialist at Merck KGaA and Félix Montero-Julian, Scientific Director of Pharma Quality Control at bioMérieux
04th December 2024
Process Equipment Related Leachable Compounds – 3 Case Studies
Presented by Dr. Tarja Nurmi, Senior Expert, Extractables & Leachables at Bayer, Pieter Van Wouwe, Scientific expert at Nelson Labs
14th November 2024
Achieving Fully Continuous End-to-End Processing
Presented by Jon Coffman, Executive Director of Bioprocess Technology and Engineering at AstraZeneca
07th November 2024
Evaluating Analytical Strategies to Quantify Capsid Titre: Towards a Platform-Method Approach to Accelerate AAV Drug Product Development
Presented by Dr. Marilia Barros, PhD, Principal Scientist Biologics & Gene Therapy Drug Product Development at Regeneron and Dr. Matt Ranaghan, Senior Applications Scientist, at Refeyn
30th October 2024
